Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway.

CAD/DFF40 is responsible for the degradation of chromosomal DNA into nucleosomal fragments and subsequent chromatin condensation during apoptosis. It exists as an inactive complex with its inhibitor ICAD/DFF45 in proliferating cells but becomes activated upon cleavage of ICAD/DFF45 into three domains by caspases in dying cells. The molecular mechanism underlying the control and activation of CAD/DFF40 was unknown. Here, the crystal structure of activated CAD/DFF40 reveals that it is a pair of molecular scissors with a deep active-site crevice that appears ideal for distinguishing internucleosomal DNA from nucleosomal DNA. Ensuing studies show that ICAD/DFF45 sequesters the nonfunctional CAD/DFF40 monomer and is also able to disassemble the functional CAD/DFF40 dimer. This capacity requires the involvement of the middle domain of ICAD/DFF45, which by itself cannot remain bound to CAD/DFF40 due to low binding affinity for the enzyme. Thus, the consequence of the caspase-cleavage of ICAD/DFF45 is a self-assembly of CAD/DFF40 into the active dimer.

[1]  S. Nagata,et al.  Functional Differences of Two Forms of the Inhibitor of Caspase-activated DNase, ICAD-L, and ICAD-S* , 1999, The Journal of Biological Chemistry.

[2]  W. Bode,et al.  Coagulation factors and their inhibitors. , 1994, Current opinion in structural biology.

[3]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[4]  L. Pedersen,et al.  Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[6]  A. Wyllie.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation , 1980, Nature.

[7]  Mei X. Wu,et al.  Functional Interaction of DFF35 and DFF45 with Caspase-activated DNA Fragmentation Nuclease DFF40* , 1999, The Journal of Biological Chemistry.

[8]  Toshio Yamazaki,et al.  Structure of the heterodimeric complex between CAD domains of CAD and ICAD , 2000, Nature Structural Biology.

[9]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[10]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[11]  Alfred Pingoud,et al.  Experimental evidence for a ββα-Me-finger nuclease motif to represent the active site of the caspase-activated DNase , 2003 .

[12]  J. D. Young,et al.  Ionophore-induced apoptosis: role of DNA fragmentation and calcium fluxes. , 1991, Experimental cell research.

[13]  A. Roulston,et al.  CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45 , 1998, Current Biology.

[14]  J. McCarty,et al.  Study of DFF45 in its role of chaperone and inhibitor: two independent inhibitory domains of DFF40 nuclease activity. , 1999, Biochemical and biophysical research communications.

[15]  P. Li,et al.  The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Atar,et al.  Excitation-Transcription Coupling Mediated by Zinc Influx through Voltage-dependent Calcium Channels (*) , 1995, The Journal of Biological Chemistry.

[17]  Yutaka Kuroda,et al.  Solution structure of the DFF-C domain of DFF45/ICAD. A structural basis for the regulation of apoptotic DNA fragmentation. , 2002, Journal of molecular biology.

[18]  C. Sander,et al.  Dali: a network tool for protein structure comparison. , 1995, Trends in biochemical sciences.

[19]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[20]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[21]  Y. Kyōgoku,et al.  Structure of the CAD domain of caspase-activated DNase and interaction with the CAD domain of its inhibitor. , 2000, Journal of molecular biology.

[22]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[23]  S. Nagata,et al.  Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis , 1998, Nature.

[24]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[25]  G. Kerchner,et al.  Measurement of Intracellular Free Zinc in Living Cortical Neurons: Routes of Entry , 1997, The Journal of Neuroscience.

[26]  Tak W. Mak,et al.  Two Distinct Pathways Leading to Nuclear Apoptosis , 2000, The Journal of experimental medicine.

[27]  Peng Li,et al.  Cleavage Preferences of the Apoptotic Endonuclease DFF40 (Caspase-activated DNase or Nuclease) on Naked DNA and Chromatin Substrates* , 2000, Journal of Biological Chemistry.

[28]  Xiaodong Wang,et al.  DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis , 1997, Cell.

[29]  J. McCarty,et al.  Multiple domains of DFF45 bind synergistically to DFF40: roles of caspase cleavage and sequestration of activator domain of DFF40. , 1999, Biochemical and biophysical research communications.

[30]  T. Simons.  Intracellular free zinc and zinc buffering in human red blood cells , 1991, The Journal of Membrane Biology.

[31]  A. Pingoud,et al.  Involvement of conserved histidine, lysine and tyrosine residues in the mechanism of DNA cleavage by the caspase-3 activated DNase CAD. , 2002, Nucleic acids research.

[32]  J. D. Young,et al.  Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation , 1994, The Journal of experimental medicine.

[33]  W. Bode,et al.  The clot thickens: clues provided by thrombin structure. , 1995, Trends in biochemical sciences.

[34]  S. Nagata,et al.  Enzymatic active site of caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD. , 2001, Archives of biochemistry and biophysics.

[35]  S. Nagata,et al.  Activation of the innate immunity in Drosophila by endogenous chromosomal DNA that escaped apoptotic degradation. , 2002, Genes & development.

[36]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[37]  B. Dahlbäck,et al.  Molecular recognition in the protein C anticoagulant pathway , 2003, Journal of thrombosis and haemostasis : JTH.

[38]  G. Wagner,et al.  Solution structure of DFF40 and DFF45 N-terminal domain complex and mutual chaperone activity of DFF40 and DFF45 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. Garrard,et al.  Ionic and cofactor requirements for the activity of the apoptotic endonuclease DFF40/CAD , 2001, Molecular and Cellular Biochemistry.

[40]  Thomas C. Terwilliger,et al.  Electronic Reprint Biological Crystallography Maximum-likelihood Density Modification , 2022 .